Convatec Group (CHIX:CTECL) Growth Rank: 6 (As of Aug. 13, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:CTECL Convatec Group PLC CHIX:CTECL
80 GF Score
Price £2.35
GF Value £2.63
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Convatec Group Growth Rank?

Convatec Group CHIX:CTECL -0.21% 80 Growth Rank is 6 as of Aug. 13, 2026, which is at its 10-year median of 6.00. GuruFocus rates CHIX:CTECL with a GF Score™ of 80/100 and a GF Value™ of £2.63 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Convatec Group has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Convatec Group Growth Rank Related Terms

CHIX:CTECL vs ISRG, BDX, MDLN: Growth Rank Comparison

For the Medical Instruments & Supplies subindustry, Convatec Group's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Convatec Group Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Growth Rank distribution charts can be found below:

* The bar in red indicates where Convatec Group's Growth Rank falls into.


CHIX:CTECL
80GF Score
Convatec Group PLC CHIX:CTECL
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 6 mean?
Convatec Group (CHIX:CTECL) has a Growth Rank of 6 as of Aug. 13, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Convatec Group and its competitors. This is near median its historical median of 6.00. Over the past decade, Convatec Group's Growth Rank has ranged from 2.00 to 8.00.
Is Convatec Group's Growth Rank too high?
Convatec Group's current Growth Rank of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. Overall, Convatec Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Growth Rank compare to ISRG and BDX?
Convatec Group's Growth Rank of 6 can be compared against companies in the Medical Devices & Instruments industry. Historically, Convatec Group's own Growth Rank has ranged from 2.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Convatec Group and its competitors. Convatec Group's current Growth Rank is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (CHIX:CTECL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.63, compared to a current price of £2.35 — trading 10.8% below its estimated fair value. The current Growth Rank is 6, which is near median its 10-year median of 6.00. Convatec Group's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Convatec Group (CHIX:CTECL), the current Growth Rank is 6 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (CHIX:CTECL) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of £2.35 is trading 10.8% below its estimated GF Value™ of £2.63. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for CHIX:CTECL:

  • Growth Rank: 6 (near median its 10-year median of 6.00)
  • GF Value™: £2.63 vs. price of £2.35 (10.8% below fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the CHIX:CTECL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
80GF Score

Get the complete analysis for CHIX:CTECL

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.35
Price
£2.63
GF Value